Drug Guide
Clotrimazole
Classification
Therapeutic: Antifungal
Pharmacological: Imidazole antifungal agent
FDA Approved Indications
- Oral candidiasis
- Vaginal candidiasis
- Cutaneous candidiasis
Mechanism of Action
Clotrimazole inhibits fungal cytochrome P450-dependent 14α-demethylase, resulting in decreased ergosterol synthesis and disruption of fungal cell membrane formation, leading to leakage of cell contents and fungal cell death.
Dosage and Administration
Adult: For vaginal candidiasis, one applicatorful (100 mg) intravaginally once daily for 7 days; for cutaneous infections, apply a thin layer to affected area twice daily for 2-4 weeks.
Pediatric: Use as directed by a healthcare provider; typically similar dosing for vaginal candidiasis, but consult specific guidelines.
Geriatric: No dose adjustment generally required; monitor for skin integrity and use in conjunction with renal or hepatic impairment as needed.
Renal Impairment: No specific adjustment needed, but caution advised.
Hepatic Impairment: No specific adjustment needed, but caution advised.
Pharmacokinetics
Absorption: Minimal systemic absorption when used topically; significant absorption when administered via oral or vaginal routes.
Distribution: Widely distributed in body tissues, especially skin and mucous membranes.
Metabolism: Metabolized in the liver via cytochrome P450 enzymes.
Excretion: Excreted mainly in urine, primarily as inactive metabolites.
Half Life: Approximately 3-4 hours when absorbed systemically.
Contraindications
- Hypersensitivity to clotrimazole or imidazoles.
Precautions
- Use with caution in patients with liver disease; monitor for signs of systemic absorption if used extensively or on large areas.
Adverse Reactions - Common
- Application site burning or itching (Common)
- Skin irritation (Common)
Adverse Reactions - Serious
- Hypersensitivity reactions (rare) (Serious)
- Systemic toxicity (very rare, with oral use) (Rare)
Drug-Drug Interactions
- Warfarin (may increase bleeding risk)
- Other CYP450 substrates or inhibitors
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for signs of allergic reactions or skin irritation; assess affected areas for improvement.
Diagnoses:
- Risk for infection
- Impaired skin integrity
Implementation: Educate patient on proper application, hygiene, and adherence to therapy schedule.
Evaluation: Assess for reduction in signs and symptoms of infection.
Patient/Family Teaching
- Use medication exactly as prescribed.
- Keep the area clean and dry before application.
- Report any severe or allergic reactions.
- Complete the full course of therapy even if symptoms improve.
Special Considerations
Black Box Warnings: N/A
Genetic Factors: No known genetic factors affecting use.
Lab Test Interference: None reported.
Overdose Management
Signs/Symptoms: Nausea, vomiting, or gastrointestinal discomfort if swallowed in excess; local irritation if topical overdose.
Treatment: Supportive care; no specific antidote. Remove unabsorbed drug/application and provide symptomatic relief.
Storage and Handling
Storage: Store at room temperature, protected from light and moisture.
Stability: Stable until expiration date when stored properly.